Navigation Links
ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results
Date:3/16/2010

Selling, general and administrative (SG&A) expenses for the fourth quarter of 2009 were $1.3 million, a decrease of $1.4 million, or 53%, compared to $2.6 million for the same period in 2008.  The decrease primarily was due to a $0.5 million decrease in personnel costs, a $0.5 million decrease in severance expenses, a $0.4 million decrease in legal and professional services, a $0.3 million decrease in consulting expenses, and a $0.1 million decrease in insurance expenses, offset in part by a $0.5 million increase in year-end bonus accrual.  

Full-Year 2009 Operating Results

ADVENTRX's net loss applicable to common stock for 2009 was $16.2 million, or $0.14 per share, compared to a net loss applicable to common stock of $26.6 million, or $0.30 per share, for 2008.  Included in the net loss applicable to common stock for 2009 was a non-cash deemed dividend expense of $4.9 million  incurred in connection with the Company's June, July, August and October 2009 equity financings. Also included in the net loss applicable to common stock for 2
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. ADVENTRX Receives Brand Name Acceptance for ANX-530
2. ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
3. ADVENTRX Announces Management Promotions
4. ADVENTRX Appoints Icahn Representative to Board of Directors
5. ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9
6. ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
7. ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
8. ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
9. ADVENTRX Pharmaceuticals Announces Closing of Financing
10. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
11. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... the development and commercialization of novel bile acid therapeutics ... of an underwritten public offering of 1,730,000 shares of ... $33.01 per share.  In addition, Intercept has granted the ... additional 259,500 shares of common stock. All ...
(Date:6/18/2013)... PROSPECT, Ill. , June 18, 2013 /PRNewswire-iReach/ ... of its new X3130 Appliance Inlet Module. The ... circuit breaker , combines a C14 appliance inlet ... one compact package.  This three-in-one device allows design ... their designs - cutting installation time by 66 ...
(Date:6/18/2013)... June 18, 2013  It has become apparent ... Seating and Mobility, a subsidiary company of The ... repair. This appears to be due to the ... field service employees.  (Logo: ... of these clients are complex mobility users with ...
Breaking Medicine Technology:Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Three-in-One X3130 Appliance Inlet Module 2
... Nov. 29, 2011 Uptake Medical® today announced the ... lung volume reduction in a patient with severe emphysema. ... endoscopic lung volume reduction system for the treatment of ... without leaving foreign materials in the lung. The patient ...
... IRVING, Texas, Nov. 29, 2011 A new study in ... has uncovered a novel mechanism that cancer cells may use ... "Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T ... Moffitt Cancer Center in Tampa, Fla., shows that a specific ...
Cached Medicine Technology:Uptake Medical Announces First Commercial Use of InterVapor for Patients With Severe Emphysema 2Uptake Medical Announces First Commercial Use of InterVapor for Patients With Severe Emphysema 3New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System 2New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System 3
(Date:6/19/2013)... “We are proud to introduce the Pond Defender. It’s ... the U.S.,” says Shaun Johnson, Retail & Mass Merchant Sales ... to a very expensive problem, considering customers pay hundreds and ... , Each package of Pond Defender features twelve discs ... any water garden or pond. The discs create a ring ...
(Date:6/19/2013)... 2013 According to Transparency Market Research ... Trends, Analysis and Forecast, 2011 – 2017,” the global ... the year 2011 and is expected to reach USD ... 9.7% from 2011 to 2017. Flexible endoscopes formed the ... USD 2,201 million for the year 2011. , Related ...
(Date:6/19/2013)... have focused on two proteins that accumulate in the ... the disease: plaques made up of the protein amyloid-beta, ... for the first time, an Alzheimer,s researcher has looked ... the interaction of the two proteins with each other ... and in mouse brains with Alzheimer,s disease. The research ...
(Date:6/19/2013)... AquaPrint Solutions in Thomson, IL is proud ... a newly-designed Harley Davidson motorcycle gas tank. A couple of ... an idea of taking a split tank motorcycle that had ... it into a work of art. , In October ... toilet seats that had been dipped in a water transfer ...
(Date:6/19/2013)... 2013 The Cancer Support Community (CSC), ... cancer care for the whole patient with the launch ... Support Community. This inaugural event, held at the Newseum, ... Ph.D., recognition of Congress members who have made a ... patients and families currently engaged in the cancer journey. ...
Breaking Medicine News(10 mins):Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 3Health News:New Alzheimer's research suggests possible cause: The interaction of proteins in the brain 2Health News:AquaPrint Solutions Transforms Harley Davidson Gas Tank into a Work Of Art for Poopy’s Pub & Grub 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 3
... , , , , , ... -- Mindray Medical,International Limited (NYSE: MR ), a ... shareholder resolutions,adopted at its annual general meeting of shareholders held ... At the meeting, Mindray Medical International,s shareholders approved the,re-election ...
... finds , FRIDAY, Dec. 18 (HealthDay News) -- Long-term ... may not be able to regain full stability while ... gait and balance become stable. However, even with prolonged ... difficulty in standing upright. Their balance can be marked ...
... Dec. 18 Memorial Blood Centers is pleased to have ... 22, 2009 at the City of Duluth Employees Blood Drive. Following ... be an open house at Memorial Blood Centers in Duluth from ... aging and unreliable bloodmobile and will allow Memorial Blood Centers to ...
... , WASHINGTON, Dec. 18 Since ... largely by the U.S. Agency for International Development (USAID), ... critical insight for decision makers to plan, monitor, and ... staff has helped conduct some 260 surveys in over ...
... blacks, study finds , FRIDAY, Dec. 18 (HealthDay News) -- ... are more likely to skip taking their meds, a new ... patients, aged 60 and older, who were interviewed at the ... year later. , Overall, whites used more medications, had more ...
... CentraCare president is new chair , ST. PAUL, Minn., ... health systems, recently elected or re-elected the following members to its board ... Chair - Terence Pladson, M.D., president, CentraCare Health System, ... Klimp, CEO, Queen of Peace Hospital, New Prague, Secretary/treasurer ...
Cached Medicine News:Health News:Mindray Medical International Limited Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting 2Health News:Alcoholics May Never Fully Regain Balance 2Health News:Memorial Blood Centers Showcases New Vehicle 2Health News:USAID Celebrates 25 Years of Demographic and Health Surveys 2Health News:Medication Adherence Varies Between Races 2Health News:Minnesota Hospital Association Elects, Re-Elects Members to Board 2
The ReSeeVit Slit Lamp System is an easy-to-use digital video imaging system that captures anterior segment and retinal images for documentation, diagnosis and patient education. The package includes...
... The 2V slit ... style slit lamp that ... vertical illumination tower and ... 16X magnification. Revolutionary design ...
... ReSeeVit 3Z slit lamp is designed to ... video ready slit lamp offers the popular ... addition to the ReSeeVit family of slit ... the market to capture clear, crisp digital ...
... The first slit lamp truly designed from ... digital video imaging. No other slit lamp ... of this exceptional product. The ReSeeVit 5V ... on the market to allow capture of ...
Medicine Products: